Loading…

Changes in circulating blood volume after infusion of hydroxyethyl starch 6% in critically ill patients

Background: The cardiovascular response to a volume challenge with hydroxyethyl starch (HES) (200/0.5) 6% depends on the relation between the volume of HES 6% infused and the expansion of the blood volume in critically ill patients. However, only relatively limited data exist on the plasma expanding...

Full description

Saved in:
Bibliographic Details
Published in:Acta anaesthesiologica Scandinavica 2001-04, Vol.45 (4), p.414-420
Main Authors: Christensen, P., Andersson, J., Rasmussen, S. E., Andersen, P. K., Henneberg, S. W.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5114-d281efe0c5d920dcd50841f372feb7f6e956e1e53cbf81155f62f99a14c440f63
cites cdi_FETCH-LOGICAL-c5114-d281efe0c5d920dcd50841f372feb7f6e956e1e53cbf81155f62f99a14c440f63
container_end_page 420
container_issue 4
container_start_page 414
container_title Acta anaesthesiologica Scandinavica
container_volume 45
creator Christensen, P.
Andersson, J.
Rasmussen, S. E.
Andersen, P. K.
Henneberg, S. W.
description Background: The cardiovascular response to a volume challenge with hydroxyethyl starch (HES) (200/0.5) 6% depends on the relation between the volume of HES 6% infused and the expansion of the blood volume in critically ill patients. However, only relatively limited data exist on the plasma expanding effect of infusion of HES 6% in critically ill patients. The purpose of the study was to evaluate the variation in the expansion of the circulating blood volume (CBV) in critically ill patients after infusion of 500 ml of colloid (HES (200/0.5) 6%) using the carbon monoxide method. Methods: In 20 consecutive patients admitted to the ICU requiring mechanical ventilation and volume expansion, 500 ml of HES (200/0.5) 6% was infused. The CBV was measured immediately before the infusion, 10 min after completing the infusion and then hourly for 8 h. Results: The median volume expansion immediately after infusion was 470 ml (range 270 ml to 840 ml). The corresponding values after 4 h and 8 h were 265 ml (range −30 ml to 460 ml) and 120 ml (range −210 ml to 360 ml), respectively. The increase in CBV was only statistically significant for 4 h. The coefficient of variation of the method for estimation of CBV was 3.6%. Conclusions: The large interindividual variation of the volume expansion after infusion of HES 6% in critically ill patients illustrates one of the difficulties in optimizing colloid therapy and interpretating the changes in hemodynamic variables after a colloid challenge.
doi_str_mv 10.1034/j.1399-6576.2001.045004414.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77056273</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77056273</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5114-d281efe0c5d920dcd50841f372feb7f6e956e1e53cbf81155f62f99a14c440f63</originalsourceid><addsrcrecordid>eNqVkE2P0zAQhi0EYrsLfwFZAvaWYMdfjcSlqmAXaQGJD7E3y3XGrYubdO0Emn-PQ6ty5mSP5pl37AehV5SUlDD-ZltSVteFFEqWFSG0JFwQwjnl5eERmp2bj9GM5HYhqKou0GVK21wyXtdP0QWlLN_VfIbWy41p15Cwb7H10Q7B9L5d41Xougb_6sKwA2xcDzETbki-a3Hn8GZsYncYod-MAafeRLvB8vXfkOh7b00II_Yh4H2Og7ZPz9ATZ0KC56fzCn1__-7b8ra4-3zzYbm4K6yglBdNNafggFjR1BVpbCPInFPHVOVgpZyEWkigIJhduTmlQjhZubo2lFvOiZPsCl0fc_exexgg9Xrnk4UQTAvdkLRSRMhKsQy-PYI2dilFcHof_c7EUVOiJ9F6qyeXenKpJ9H6LFof8viL055htYPm3_DJbAZengCTsg4XTWt9OnP5d0RO1PJI_fYBxv96gl4svuaKE55TimOKTz0czikm_tRSMSX0j083-p5_-XhL1L1W7A-48qpf</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77056273</pqid></control><display><type>article</type><title>Changes in circulating blood volume after infusion of hydroxyethyl starch 6% in critically ill patients</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Christensen, P. ; Andersson, J. ; Rasmussen, S. E. ; Andersen, P. K. ; Henneberg, S. W.</creator><creatorcontrib>Christensen, P. ; Andersson, J. ; Rasmussen, S. E. ; Andersen, P. K. ; Henneberg, S. W.</creatorcontrib><description>Background: The cardiovascular response to a volume challenge with hydroxyethyl starch (HES) (200/0.5) 6% depends on the relation between the volume of HES 6% infused and the expansion of the blood volume in critically ill patients. However, only relatively limited data exist on the plasma expanding effect of infusion of HES 6% in critically ill patients. The purpose of the study was to evaluate the variation in the expansion of the circulating blood volume (CBV) in critically ill patients after infusion of 500 ml of colloid (HES (200/0.5) 6%) using the carbon monoxide method. Methods: In 20 consecutive patients admitted to the ICU requiring mechanical ventilation and volume expansion, 500 ml of HES (200/0.5) 6% was infused. The CBV was measured immediately before the infusion, 10 min after completing the infusion and then hourly for 8 h. Results: The median volume expansion immediately after infusion was 470 ml (range 270 ml to 840 ml). The corresponding values after 4 h and 8 h were 265 ml (range −30 ml to 460 ml) and 120 ml (range −210 ml to 360 ml), respectively. The increase in CBV was only statistically significant for 4 h. The coefficient of variation of the method for estimation of CBV was 3.6%. Conclusions: The large interindividual variation of the volume expansion after infusion of HES 6% in critically ill patients illustrates one of the difficulties in optimizing colloid therapy and interpretating the changes in hemodynamic variables after a colloid challenge.</description><identifier>ISSN: 0001-5172</identifier><identifier>EISSN: 1399-6576</identifier><identifier>DOI: 10.1034/j.1399-6576.2001.045004414.x</identifier><identifier>PMID: 11300378</identifier><identifier>CODEN: AANEAB</identifier><language>eng</language><publisher>Copenhagen: Munksgaard International Publishers</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Algorithms ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Blood volume ; Blood Volume - drug effects ; Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis ; carbon monoxide ; Carbon Monoxide - blood ; colloids ; Critical Illness ; Female ; Hematocrit ; Humans ; hydroxyethyl starch ; Hydroxyethyl Starch Derivatives - pharmacology ; intensive care ; Male ; Medical sciences ; Middle Aged ; Plasma Substitutes - pharmacology ; plasma volume ; Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><ispartof>Acta anaesthesiologica Scandinavica, 2001-04, Vol.45 (4), p.414-420</ispartof><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5114-d281efe0c5d920dcd50841f372feb7f6e956e1e53cbf81155f62f99a14c440f63</citedby><cites>FETCH-LOGICAL-c5114-d281efe0c5d920dcd50841f372feb7f6e956e1e53cbf81155f62f99a14c440f63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=920068$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11300378$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Christensen, P.</creatorcontrib><creatorcontrib>Andersson, J.</creatorcontrib><creatorcontrib>Rasmussen, S. E.</creatorcontrib><creatorcontrib>Andersen, P. K.</creatorcontrib><creatorcontrib>Henneberg, S. W.</creatorcontrib><title>Changes in circulating blood volume after infusion of hydroxyethyl starch 6% in critically ill patients</title><title>Acta anaesthesiologica Scandinavica</title><addtitle>Acta Anaesthesiol Scand</addtitle><description>Background: The cardiovascular response to a volume challenge with hydroxyethyl starch (HES) (200/0.5) 6% depends on the relation between the volume of HES 6% infused and the expansion of the blood volume in critically ill patients. However, only relatively limited data exist on the plasma expanding effect of infusion of HES 6% in critically ill patients. The purpose of the study was to evaluate the variation in the expansion of the circulating blood volume (CBV) in critically ill patients after infusion of 500 ml of colloid (HES (200/0.5) 6%) using the carbon monoxide method. Methods: In 20 consecutive patients admitted to the ICU requiring mechanical ventilation and volume expansion, 500 ml of HES (200/0.5) 6% was infused. The CBV was measured immediately before the infusion, 10 min after completing the infusion and then hourly for 8 h. Results: The median volume expansion immediately after infusion was 470 ml (range 270 ml to 840 ml). The corresponding values after 4 h and 8 h were 265 ml (range −30 ml to 460 ml) and 120 ml (range −210 ml to 360 ml), respectively. The increase in CBV was only statistically significant for 4 h. The coefficient of variation of the method for estimation of CBV was 3.6%. Conclusions: The large interindividual variation of the volume expansion after infusion of HES 6% in critically ill patients illustrates one of the difficulties in optimizing colloid therapy and interpretating the changes in hemodynamic variables after a colloid challenge.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Algorithms</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Blood volume</subject><subject>Blood Volume - drug effects</subject><subject>Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis</subject><subject>carbon monoxide</subject><subject>Carbon Monoxide - blood</subject><subject>colloids</subject><subject>Critical Illness</subject><subject>Female</subject><subject>Hematocrit</subject><subject>Humans</subject><subject>hydroxyethyl starch</subject><subject>Hydroxyethyl Starch Derivatives - pharmacology</subject><subject>intensive care</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Plasma Substitutes - pharmacology</subject><subject>plasma volume</subject><subject>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><issn>0001-5172</issn><issn>1399-6576</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqVkE2P0zAQhi0EYrsLfwFZAvaWYMdfjcSlqmAXaQGJD7E3y3XGrYubdO0Emn-PQ6ty5mSP5pl37AehV5SUlDD-ZltSVteFFEqWFSG0JFwQwjnl5eERmp2bj9GM5HYhqKou0GVK21wyXtdP0QWlLN_VfIbWy41p15Cwb7H10Q7B9L5d41Xougb_6sKwA2xcDzETbki-a3Hn8GZsYncYod-MAafeRLvB8vXfkOh7b00II_Yh4H2Og7ZPz9ATZ0KC56fzCn1__-7b8ra4-3zzYbm4K6yglBdNNafggFjR1BVpbCPInFPHVOVgpZyEWkigIJhduTmlQjhZubo2lFvOiZPsCl0fc_exexgg9Xrnk4UQTAvdkLRSRMhKsQy-PYI2dilFcHof_c7EUVOiJ9F6qyeXenKpJ9H6LFof8viL055htYPm3_DJbAZengCTsg4XTWt9OnP5d0RO1PJI_fYBxv96gl4svuaKE55TimOKTz0czikm_tRSMSX0j083-p5_-XhL1L1W7A-48qpf</recordid><startdate>200104</startdate><enddate>200104</enddate><creator>Christensen, P.</creator><creator>Andersson, J.</creator><creator>Rasmussen, S. E.</creator><creator>Andersen, P. K.</creator><creator>Henneberg, S. W.</creator><general>Munksgaard International Publishers</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200104</creationdate><title>Changes in circulating blood volume after infusion of hydroxyethyl starch 6% in critically ill patients</title><author>Christensen, P. ; Andersson, J. ; Rasmussen, S. E. ; Andersen, P. K. ; Henneberg, S. W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5114-d281efe0c5d920dcd50841f372feb7f6e956e1e53cbf81155f62f99a14c440f63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Algorithms</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Blood volume</topic><topic>Blood Volume - drug effects</topic><topic>Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis</topic><topic>carbon monoxide</topic><topic>Carbon Monoxide - blood</topic><topic>colloids</topic><topic>Critical Illness</topic><topic>Female</topic><topic>Hematocrit</topic><topic>Humans</topic><topic>hydroxyethyl starch</topic><topic>Hydroxyethyl Starch Derivatives - pharmacology</topic><topic>intensive care</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Plasma Substitutes - pharmacology</topic><topic>plasma volume</topic><topic>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Christensen, P.</creatorcontrib><creatorcontrib>Andersson, J.</creatorcontrib><creatorcontrib>Rasmussen, S. E.</creatorcontrib><creatorcontrib>Andersen, P. K.</creatorcontrib><creatorcontrib>Henneberg, S. W.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Acta anaesthesiologica Scandinavica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Christensen, P.</au><au>Andersson, J.</au><au>Rasmussen, S. E.</au><au>Andersen, P. K.</au><au>Henneberg, S. W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Changes in circulating blood volume after infusion of hydroxyethyl starch 6% in critically ill patients</atitle><jtitle>Acta anaesthesiologica Scandinavica</jtitle><addtitle>Acta Anaesthesiol Scand</addtitle><date>2001-04</date><risdate>2001</risdate><volume>45</volume><issue>4</issue><spage>414</spage><epage>420</epage><pages>414-420</pages><issn>0001-5172</issn><eissn>1399-6576</eissn><coden>AANEAB</coden><abstract>Background: The cardiovascular response to a volume challenge with hydroxyethyl starch (HES) (200/0.5) 6% depends on the relation between the volume of HES 6% infused and the expansion of the blood volume in critically ill patients. However, only relatively limited data exist on the plasma expanding effect of infusion of HES 6% in critically ill patients. The purpose of the study was to evaluate the variation in the expansion of the circulating blood volume (CBV) in critically ill patients after infusion of 500 ml of colloid (HES (200/0.5) 6%) using the carbon monoxide method. Methods: In 20 consecutive patients admitted to the ICU requiring mechanical ventilation and volume expansion, 500 ml of HES (200/0.5) 6% was infused. The CBV was measured immediately before the infusion, 10 min after completing the infusion and then hourly for 8 h. Results: The median volume expansion immediately after infusion was 470 ml (range 270 ml to 840 ml). The corresponding values after 4 h and 8 h were 265 ml (range −30 ml to 460 ml) and 120 ml (range −210 ml to 360 ml), respectively. The increase in CBV was only statistically significant for 4 h. The coefficient of variation of the method for estimation of CBV was 3.6%. Conclusions: The large interindividual variation of the volume expansion after infusion of HES 6% in critically ill patients illustrates one of the difficulties in optimizing colloid therapy and interpretating the changes in hemodynamic variables after a colloid challenge.</abstract><cop>Copenhagen</cop><pub>Munksgaard International Publishers</pub><pmid>11300378</pmid><doi>10.1034/j.1399-6576.2001.045004414.x</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0001-5172
ispartof Acta anaesthesiologica Scandinavica, 2001-04, Vol.45 (4), p.414-420
issn 0001-5172
1399-6576
language eng
recordid cdi_proquest_miscellaneous_77056273
source Wiley-Blackwell Read & Publish Collection
subjects Adult
Aged
Aged, 80 and over
Algorithms
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Blood volume
Blood Volume - drug effects
Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis
carbon monoxide
Carbon Monoxide - blood
colloids
Critical Illness
Female
Hematocrit
Humans
hydroxyethyl starch
Hydroxyethyl Starch Derivatives - pharmacology
intensive care
Male
Medical sciences
Middle Aged
Plasma Substitutes - pharmacology
plasma volume
Transfusions. Complications. Transfusion reactions. Cell and gene therapy
title Changes in circulating blood volume after infusion of hydroxyethyl starch 6% in critically ill patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T11%3A59%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Changes%20in%20circulating%20blood%20volume%20after%20infusion%20of%20hydroxyethyl%20starch%206%25%20in%20critically%20ill%20patients&rft.jtitle=Acta%20anaesthesiologica%20Scandinavica&rft.au=Christensen,%20P.&rft.date=2001-04&rft.volume=45&rft.issue=4&rft.spage=414&rft.epage=420&rft.pages=414-420&rft.issn=0001-5172&rft.eissn=1399-6576&rft.coden=AANEAB&rft_id=info:doi/10.1034/j.1399-6576.2001.045004414.x&rft_dat=%3Cproquest_cross%3E77056273%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5114-d281efe0c5d920dcd50841f372feb7f6e956e1e53cbf81155f62f99a14c440f63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=77056273&rft_id=info:pmid/11300378&rfr_iscdi=true